Literature DB >> 28082101

Negative Regulation of Type 2 Immunity.

Dimitri A de Kouchkovsky1, Sourav Ghosh2, Carla V Rothlin3.   

Abstract

Type 2 immunity encompasses the mechanisms through which the immune system responds to helminths and an array of environmental substances such as allergens. In the developing world, billions of individuals are chronically infected with endemic parasitic helminths. In comparison, in the industrialized world, millions of individuals suffer from dysregulated type 2 immunity, referred to clinically as atopic diseases including asthma, allergic rhinitis, and atopic dermatitis. Thus, type 2 immunity must be carefully regulated to mount protective host responses yet avoid inappropriate activation and immunopathology. In this review, we describe the key players and connections at play in type 2 responses and focus on the emerging mechanisms involved in the negative regulation of type 2 immunity.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28082101      PMCID: PMC5510550          DOI: 10.1016/j.it.2016.12.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  121 in total

Review 1.  TSLP expression: cellular sources, triggers, and regulatory mechanisms.

Authors:  Toshiro Takai
Journal:  Allergol Int       Date:  2012-01-25       Impact factor: 5.836

Review 2.  Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease.

Authors:  Steven J Van Dyken; Richard M Locksley
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

3.  MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.

Authors:  Kristina Johansson; Carina Malmhäll; Patricia Ramos-Ramírez; Madeleine Rådinger
Journal:  J Allergy Clin Immunol       Date:  2016-08-01       Impact factor: 10.793

4.  Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat.

Authors:  Yifu Qiu; Khoa D Nguyen; Justin I Odegaard; Xiaojin Cui; Xiaoyu Tian; Richard M Locksley; Richard D Palmiter; Ajay Chawla
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

5.  Dedicator of cytokinesis 8-deficient CD4+ T cells are biased to a TH2 effector fate at the expense of TH1 and TH17 cells.

Authors:  Stuart G Tangye; Bethany Pillay; Katrina L Randall; Danielle T Avery; Tri Giang Phan; Paul Gray; John B Ziegler; Joanne M Smart; Jane Peake; Peter D Arkwright; Sophie Hambleton; Jordan Orange; Christopher C Goodnow; Gulbu Uzel; Jean-Laurent Casanova; Saul Oswaldo Lugo Reyes; Alexandra F Freeman; Helen C Su; Cindy S Ma
Journal:  J Allergy Clin Immunol       Date:  2016-08-20       Impact factor: 10.793

6.  The killing of newborn larvae of Trichinella spiralis by eosinophil peroxidase in vitro.

Authors:  J Buys; R Wever; R van Stigt; E J Ruitenberg
Journal:  Eur J Immunol       Date:  1981-10       Impact factor: 5.532

7.  Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut.

Authors:  Michael R Howitt; Sydney Lavoie; Monia Michaud; Arthur M Blum; Sara V Tran; Joel V Weinstock; Carey Ann Gallini; Kevin Redding; Robert F Margolskee; Lisa C Osborne; David Artis; Wendy S Garrett
Journal:  Science       Date:  2016-02-04       Impact factor: 47.728

8.  TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand.

Authors:  Tomoki Ito; Yui-Hsi Wang; Omar Duramad; Toshiyuki Hori; Guy J Delespesse; Norihiko Watanabe; F Xiao-Feng Qin; Zhengbin Yao; Wei Cao; Yong-Jun Liu
Journal:  J Exp Med       Date:  2005-11-07       Impact factor: 14.307

Review 9.  Regulation of Macrophage, Dendritic Cell, and Microglial Phenotype and Function by the SOCS Proteins.

Authors:  Sarah M McCormick; Nicola M Heller
Journal:  Front Immunol       Date:  2015-10-27       Impact factor: 7.561

10.  TFH cells progressively differentiate to regulate the germinal center response.

Authors:  Jason S Weinstein; Edward I Herman; Begoña Lainez; Paula Licona-Limón; Enric Esplugues; Richard Flavell; Joe Craft
Journal:  Nat Immunol       Date:  2016-08-29       Impact factor: 25.606

View more
  11 in total

Review 1.  Dual oxidase: a novel therapeutic target in allergic disease.

Authors:  Albert van der Vliet; Karamatullah Danyal; David E Heppner
Journal:  Br J Pharmacol       Date:  2018-03-15       Impact factor: 8.739

Review 2.  Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis.

Authors:  El-Bdaoui Haddad; Sonya L Cyr; Kazuhiko Arima; Robert A McDonald; Noah A Levit; Frank O Nestle
Journal:  Dermatol Ther (Heidelb)       Date:  2022-05-21

3.  Identification of a lncRNA AC011511.5- Mediated Competitive Endogenous RNA Network Involved in the Pathogenesis of Allergic Rhinitis.

Authors:  Yujuan Yang; Qi Sun; Jing Guo; Zhen Liu; Jianwei Wang; Yao Yao; Pengyi Yu; Jiayu Cao; Yu Zhang; Xicheng Song
Journal:  Front Genet       Date:  2022-05-31       Impact factor: 4.772

Review 4.  Regulation of myeloid-cell activation.

Authors:  Joseph T Greene; Ben F Brian; S Erandika Senevirathne; Tanya S Freedman
Journal:  Curr Opin Immunol       Date:  2021-10-01       Impact factor: 7.486

5.  Paeonol inhibits the development of 1‑chloro‑2,4‑dinitrobenzene‑induced atopic dermatitis via mast and T cells in BALB/c mice.

Authors:  Yujiao Meng; Zhengrong Liu; Chunyan Zhai; Tingting Di; Lu Zhang; Lei Zhang; Xinran Xie; Yan Lin; Ning Wang; Jingxia Zhao; Yan Wang; Ping Li
Journal:  Mol Med Rep       Date:  2019-02-25       Impact factor: 2.952

6.  Modulation of Allergic Reactivity in Humans Is Dependent on Schistosoma mansoni Parasite Burden, Low Levels of IL-33 or TNF-α and High Levels of IL-10 in Serum.

Authors:  Samira D Resende; Fernanda C Magalhães; Jailza L Rodrigues-Oliveira; Vanessa N Castro; Carolina S A Souza; Edward J Oliveira; Mariângela Carneiro; Stefan M Geiger; Deborah A Negrão-Corrêa
Journal:  Front Immunol       Date:  2019-01-18       Impact factor: 7.561

7.  GAS6 signaling tempers Th17 development in patients with multiple sclerosis and helminth infection.

Authors:  Juan M Ortiz Wilczyñski; Cinthia M Olexen; Andrea E Errasti; Mirta Schattner; Carla V Rothlin; Jorge Correale; Eugenio A Carrera Silva
Journal:  PLoS Pathog       Date:  2020-12-21       Impact factor: 6.823

Review 8.  Impact of Therapeutics on Unified Immunity During Allergic Asthma and Respiratory Infections.

Authors:  Armando S Flores-Torres; Amali E Samarasinghe
Journal:  Front Allergy       Date:  2022-03-25

Review 9.  Worms: Pernicious parasites or allies against allergies?

Authors:  Henry J McSorley; Mathilde A M Chayé; Hermelijn H Smits
Journal:  Parasite Immunol       Date:  2018-08-29       Impact factor: 2.280

Review 10.  Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target.

Authors:  Jie Jin; Sadik Sunusi; Hongyan Lu
Journal:  J Int Med Res       Date:  2022-01       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.